Trial Profile
Feasibility and tolerability of telaprevir (TVR) in multimorbid HCV infected patients under hemodialysis: A multicenter, retrospective analysis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 17 Dec 2015
Price :
$35
*
At a glance
- Drugs Telaprevir (Primary)
- Indications Hepatitis C
- Focus Adverse reactions; Therapeutic Use
- 17 Dec 2015 New trial record